Johns Hopkins Singapore

Singapore 308433

0 studies enrolling now · 4 studies all time

What they study most

Nasopharyngeal Nonkeratinizing Carcinoma, Non-Small-Cell Lung Carcinoma, Recurrent Nasopharynx Carcinoma, Recurrent Small Cell Lung Carcinoma, Recurrent Thyroid Gland Carcinoma, Stage III Differentiated Thyroid Gland Carcinoma AJCC v7, Stage III Nasopharyngeal Carcinoma AJCC v7, Stage III Thyroid Gland Medullary Carcinoma AJCC v7, Stage IV Nasopharyngeal Carcinoma AJCC v7, Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7, Stage IVA Nasopharyngeal Carcinoma AJCC v7, Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7

Studies at this site

• Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer — Completed
• Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer — Completed
• A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed
• Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer — Completed